This secondary analysis of a randomized clinical trial examines relative vaccine effectiveness of high-dose vs standard-dose inactivated influenza vaccines against severe respiratory and cardiovascular outcomes according to diabetes status and across diabetes subgroups.
JAMA Internal Medicine published a clinical update in Research Highlights on 01 Mar 2026.
The item focuses on High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Diabetes.
Review the original article for the full source wording and details.